In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk.
Ann Intern Med
; 174(10): JC110, 2021 10.
Article
en En
| MEDLINE
| ID: mdl-34606316
ABSTRACT
SOURCE CITATION Jankowska EA, Kirwan BA, Kosiborod M, et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure the results of the AFFIRM-AHF study. Eur Heart J. 2021;423011-20. 34080008.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Anemia Ferropénica
/
Insuficiencia Cardíaca
Límite:
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article